BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Activity
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

170 hedge funds and large institutions have $1.98B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2019 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+39
Holders Change %
+29.77%
% of All Funds
3.69%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.26%
New
51
Increased
60
Reduced
34
Closed
11
Calls
$57.2M
Puts
$24.9M
Net Calls
+$32.4M
Net Calls Change
+$26M

Top Buyers

1
OIM
Oracle Investment Management
Connecticut
+$43.6M
2
BlackRock
BlackRock
New York
+$24M
3
CAM
Cormorant Asset Management
Massachusetts
+$23.2M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$18.6M
5
State Street
State Street
Massachusetts
+$16.9M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$97.4M
2
VC
Vivo Capital
California
-$67.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$19.8M
4
TCIM
TIAA CREF Investment Management
New York
-$19.5M
5
FCMI
Foresite Capital Management IV
California
-$17.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Russell Investments Group
176
Russell Investments Group
United Kingdom
– -$472K -12,755 Closed
TI
177
Trexquant Investment
Connecticut
– -$232K -6,276 Closed
TRCT
178
Tower Research Capital (TRC)
New York
– -$128K -3,470 Closed
HMS
179
Hanseatic Management Services
New Mexico
– -$2K -41 Closed
4 5 6 7
8